Showing results (1571-1580 of 1,658) with videos related to
Sort By:
Pageof 166
European Radiology|March 29, 2022
Clinical impact of assessing thrombus age using magnetic resonance venography prior to catheter-directed thrombolysisCarsten W K P Arnoldussen, Pascale Notten, Rutger Brans, et al.Targeted Oncology|December 27, 2015
Aflibercept Plus FOLFIRI vs. Placebo Plus FOLFIRI in Second-Line Metastatic Colorectal Cancer: a Post Hoc Analysis of Survival from the Phase III VELOUR Study Subsequent to Exclusion of Patients who had Recurrence During or Within 6 Months of Completing Adjuvant Oxaliplatin-Based TherapyEric Van Cutsem, Florence Joulain, Paulo M Hoff, et al.Journal of Thrombosis and Haemostasis : JTH|June 2, 2018
Clinical and economic impact of compression in the acute phase of deep vein thrombosisE E Amin, M A Joore, H Ten Cate, et al.Gut|March 4, 2015
Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)K Nadine Phoa, Roos E Pouw, Raf Bisschops, et al.Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|July 14, 2021
The challenge of choosing in cardiovascular risk managementR M Hoogeveen, N M J Hanssen, J R Brouwer, et al.European Journal of Radiology|May 1, 2026
The standardized thyroid ultrasound report in a regional thyroid network in the Netherlands: a mixed-methods implementation analysisH I Coerts, C M C Oude Ophuis, M Medici, et al.Viruses|January 23, 2024
Incidence and Severity of COVID-19 in Relation to Anti-Receptor-Binding Domain IgG Antibody Level after COVID-19 Vaccination in Kidney Transplant RecipientsA Lianne Messchendorp, Jan-Stephan F Sanders, Alferso C Abrahams, et al.Neurosurgery|February 26, 2015
Time course and risk factors for myocardial dysfunction after aneurysmal subarachnoid hemorrhageIvo A van der Bilt, Djo Hasan, Renee B van den Brink, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2017
Maintenance treatment with capecitabine and bevacizumab versus observation in metastatic colorectal cancer: updated results and molecular subgroup analyses of the phase 3 CAIRO3 studyK K H Goey, S G Elias, H van Tinteren, et al.Cancer|June 18, 2016
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trialJan C Drooger, Harm van Tinteren, Steffen M de Groot, et al.Pageof 166